logo
Plus   Neg
Share
Email

Lupin Reports European Commission Approval Of NaMuscla - Quick Facts

Lupin (LUPIN) announced that the European Commission has approved NaMuscla (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders. Lupin is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter of 2019. The company has partnering discussions ongoing for commercialization of NaMuscla in European territories outside Germany and the UK.

The company noted that the approval makes NaMuscla the first treatment to be licensed throughout the EU for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
erman software giant SAP SE announced the launch of its blockchain-based supply chain tracking system that helps eliminate counterfeit drugs along the pharmaceutical supply chain. In a statement, the company noted that its blockchain-based solution helps customers comply with the U.S. Drug Supply Chain Security Act or DSCSA. Ford Motor Co. plans to launch an all-electric plugin version of its popular F-150 pickup truck. The announcement was made by Jim Farley, Ford's president of Global Markets, during a presentation at the Deutsche Bank Global Automotive Conference in Detroit. Ford's announcement comes as the auto industry transitions away from fossil fuel-powered transportation to electric vehicles. Logistics giant UPS' investment arm Strategic Enterprise fund made an equity investment in blockchain-for-business company Inxeption Corp. In a statement, Inxeption, an industrial-strength eCommerce platform built on Blockchain, said the investment will be used to create innovative new e-commerce solutions for B2B sellers and buyers.
Follow RTT